GASTRIC CANCER SCREENING COST EFFICIENCY ANALYSES USING BIOMARKERS

The aim of the research was to analyze cost efficiency of gastric cancer organized and selected screenings of the population in Latvia. During the research there were calculated gastric cancer treatment costs through disease stages of the patients in Latvia. According to the objective of the research there were calculated loss for the national economy caused by gastric cancer without any prevention activities taking into account, the cost of treatment and value of lost years of life. Loss for the national economy caused by gastric cancer is 30 MM annually without any prevention activities, over 150 MM annually with organized screening with trend to increase by increasing participation rate. If voluntarily screening takes place, there are no loss for national economy and gain for the national economy exceeds 1 MM in 7 years period. These results lead to significant conclusions for the policy makers.